I AM ALS is a nonprofit patient-advocacy group focused on amyotrophic lateral sclerosis (ALS). It lobbies Congress for federal funding for ALS research in annual appropriations bills, support for medical and clinical research programs (including ARPA-H), and for FDA-related legislation and specific ALS measures like The ACT for ALS. It hires a professional lobbying firm to advance these funding and health-policy priorities.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr MICHAEL A MEROLA
The latest disclosures for this client.
WINNING STRATEGIES WASHINGTON
2AWINNING STRATEGIES WASHINGTON
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
WINNING STRATEGIES WASHINGTON
NANCY FOX
WINNING STRATEGIES WASHINGTON
WINNING STRATEGIES WASHINGTON
Q1WINNING STRATEGIES WASHINGTON
Q4WINNING STRATEGIES WASHINGTON
Q3WINNING STRATEGIES WASHINGTON
Q2WINNING STRATEGIES WASHINGTON
Q1